Vera Therapeutics Inc - Ordinary Shares - Class A
VERA
Market Cap$1.44B
Close$
$0.69
97.1% downside
Current Fair Value
97.1% downsideOvervalued by 97.1% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $1.44 Billion |
|---|---|
| Enterprise Value | $1.45 Billion |
| Dividend Yield | $0 (0%) |
| Earnings per Share | $-2.75 |
| Beta | 1.13 |
| Outstanding Shares | 63,671,558 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | -8.22 |
|---|---|
| PEG | -10.01 |
| Price to Sales | - |
| Price to Book Ratio | 3.0 |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | -7.82 |
| Enterprise Value to Net Income | -9 |
| Total Debt to Enterprise | 0.04 |
| Debt to Equity | 0.12 |
Revenue Sources
No data
Insider Trades
ESG Score
No data
About Vera Therapeutics Inc
19 employees